Bristol's $300 Mil. Settlement Leaves $170 Mil. In Reserve For Wholesaler Litigation

The company settles a securities class action related to wholesaler inventory accounting practices and Bristol's investment in ImClone's oncologic Erbitux. The settlement awaits final approval by Manhattan district court.